Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes
Author:
Funder
Diabetes UK
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00125-019-4918-x.pdf
Reference33 articles.
1. Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20(6):876–913. https://doi.org/10.1210/edrv.20.6.0385
2. Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375(4):311–322. https://doi.org/10.1056/NEJMoa1603827
3. Marso SP, Bain SC, Consoli A et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375(19):1834–1844. https://doi.org/10.1056/NEJMoa1607141
4. Selley E, Kun S, Szijarto IA et al (2014) Exenatide induces aortic vasodilation increasing hydrogen sulphide, carbon monoxide and nitric oxide production. Cardiovasc Diabetol 13(1):69. https://doi.org/10.1186/1475-2840-13-69
5. Sjoberg KA, Holst JJ, Rattigan S et al (2014) GLP-1 increases microvascular recruitment but not glucose uptake in human and rat skeletal muscle. Am J Physiol Endocrinol Metab 306(4):E355–E362. https://doi.org/10.1152/ajpendo.00283.2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? Insights from post-hoc analysis of EXSCEL;Diabetes Research and Clinical Practice;2024-06
2. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule;Cell Metabolism;2024-06
3. Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease;Frontiers in Pharmacology;2024-04-24
4. Effects of foam rolling on vastus intermedius and lateralis microvascular blood flow;Journal of Bodywork and Movement Therapies;2023-10
5. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders;Pharmaceuticals;2022-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3